Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

CN Bio’s liver model recreates highly functional and metabolically ... in response to increasing demand for human-relevant, preclinical toxicology testing. With Human 24, PhysioMimix users can now ...

Charles River Laboratories International Inc (NYSE:CRL) reported fourth-quarter 2024 revenue of $1 billion, a decrease of 1.1 ...

Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States Patent and Trademark Office (USPTO) has allowed a patent application directed ...

Research Models and Services sales increased 4.3% ... release reinforced the view that Charles River remains the premier preclinical CRO, and the analyst is confident in its best-in-class offerings.

Our group’s long-term goal is to develop specific biomarkers for detecting cancers and to evaluate these biomarkers in pre-clinical cancer models Notwithstanding the remarkable clinical success of mAb ...

Thanks to its capacity to detect patterns and stay consistent, machine learning is a great tool for CNS behaviour studies.